Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 03, 2024

SELL
$4.38 - $6.48 $37,230 - $55,080
-8,500 Reduced 1.71%
488,135 $2.44 Billion
Q2 2024

Aug 14, 2024

BUY
$4.38 - $6.48 $2.18 Million - $3.22 Million
496,635 New
496,635 $4.41 Billion

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.